XU Gang. Value of combined detection of urinary albumin-to-creatinine ratio, β2 microglobulin and retinol binding protein in early diagnosis of diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2020, 24(21): 86-89. DOI: 10.7619/jcmp.202021025
Citation: XU Gang. Value of combined detection of urinary albumin-to-creatinine ratio, β2 microglobulin and retinol binding protein in early diagnosis of diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2020, 24(21): 86-89. DOI: 10.7619/jcmp.202021025

Value of combined detection of urinary albumin-to-creatinine ratio, β2 microglobulin and retinol binding protein in early diagnosis of diabetic nephropathy

More Information
  • Received Date: August 12, 2020
  • Available Online: December 21, 2020
  • Published Date: November 23, 2020
  • Objective To investigate the value of urinary albumin-to-creatinine ratio(ACR), β2 microglobulin(β2-MG)and retinol binding protein(RBP)in early diagnosis of renal damage in diabetic patients. Methods A total of 96 patients with diabetes who were treated in our hospital were selected as research objects, and were divided into diabetic nephropathy group(n=49)and diabetes group(n=47)according to the qualitative test results of urinary protein. Another 50 healthy patients who underwent physical examination in the outpatient department during the same period were selected as healthy group. The levels of ACR, β2-MG and RBP were detected and compared in three groups, and sensitivity, specificity and accuracy of detection of ACR, β2-MG or RBP alone and their combination were calculated. Results The levels of urinary ACR, β2-MG and RBP in the diabetic nephropathy group were significantly higher than those in diabetes group and healthy group(P<0.05). The positive rates of detection of ACR, β2-MG or RBP alone and their combination in the diabetic nephropathy group were significantly higher than that in the diabetes group(P<0.05). The sensitivity, specificity and accuracy of combined detection of urinary ACR, β2-MG and RBP in diagnosis of diabetic nephropathy were 95.92%, 85.57% and 89.04%, respectively, and there were significant differences in sensitivity and accuracy between single detection and combined detection(P<0.05), but no significant difference was found in specificity(P>0.05). Conclusion Urinary ACR, β2-MG and RBP levels can reflect early renal injury degree in diabetic patients, and combined detection has better - sensitivity and accuracy in diagnosis of diabetic nephropathy.
  • 梁霞, 田甜, 赵爱巧, 等. 尿ACR联合尿β2-MG检测在妊娠合并糖尿病早期肾损害诊断中的临床应用[J]. 临床与病理杂志, 2018, 38(9): 1890-1896.
    梁涛, 张晓宝, 张德太, 等. 3项指标联合检测在糖尿病肾病中的早期诊断价值[J]. 临床血液学杂志: 输血与检验, 2019, 32(4): 247-251.
    梁霞, 韩翠欣, 刘欢, 等. 尿微量白蛋白与尿肌酐比值、尿微量白蛋白及尿β2-微球蛋白检测诊断妊娠期糖尿病早期肾损害的价值[J]. 现代中西医结合杂志, 2019, 11(23): 2544-2547.
    黄斯伟. 糖尿病肾病血清α1-微球蛋白和β2-微球蛋白联合尿视黄醇结合蛋白检测价值研究[J]. 中国预防医学杂志, 2019, 20(3): 233-235.
    刘莉, 张军. 血清Cys C、β2-MG与尿kim-1、M-ALB联合检测在早期糖尿病肾病诊断中的价值[J]. 检验医学与临床, 2018, 15(23): 3515-3517.
    黎明, 徐雯. 血清同型半胱氨酸、血清胱抑素-C、尿β2-微球蛋白联合检测对早期诊断糖尿病肾病准确性分析[J]. 国际免疫学杂志, 2018, 41(4): 430-433.
    刘辉, 孙懿, 姚英. 肾小管损伤标志物检测对慢性肾脏病高危人群的意义及影响因素研究[J]. 临床肾脏病杂志, 2019, 22(9): 530-533.
    张翠静, 唐宏霞, 鲍喜静, 等. 血清中MicroRNA-130b表达在评估2型糖尿病患者早期肾脏损伤中的价值[J]. 中国临床医生杂志, 2018, 46(1): 35-38.
    吴惠兰, 毛春芬, 陈晓君. 联合检测血清降钙素原、血清前白蛋白和视黄醇结合蛋白对脓毒血症早期诊断的价值[J]. 中国医师进修杂志, 2019, 42(12): 1093-1096.
    苏洋, 梅秋雁. 血浆NGAL, Cys C和尿NAG/Crea联合检测对早期糖尿病肾病诊断价值的研究[J]. 现代检验医学杂志, 2018, 33(1): 99-101

    , 105.
    何艳红. 尿微量白蛋白和血清、尿β2微球蛋白联合检测在诊断糖尿病早期肾病的临床应用价值[J]. 临床检验杂志: 电子版, 2019, 8(4): 75-76.
    王雪, 蔡立夫, 王堃. 血清RBP、β2-MG、CysC水平联合检测对妊娠期糖尿病待产妇患者早期肾损害阳性检出率的影响[J]. 中国实验诊断学, 2019, 23(2): 266-268.
    杨琴, 王团美, 王曼知, 等. 联合检测尿微量白蛋白肌酐比值、尿视黄醇结合蛋白、血清胱抑素C早期诊断窒息新生儿肾功能损伤的意义[J]. 现代中西医结合杂志, 2018, 27(14): 1565-1567.
    张如霖, 王弘明, 彭霞, 等. 血清淀粉样蛋白A、胱抑素C与尿白蛋白/肌酐比值联合检测在早期糖尿病肾病中的诊断价值[J]. 检验医学, 2018, 33(2): 97-100.
    郑莹莹. 糖尿病患者血清胱抑素C、尿RBP水平变化及其与Scr和Ccr的关系[J]. 山东医药, 2019, 59(4): 64-66.
    罗丹. 5项指标联合检测对早期糖尿病肾病的诊断价值[J]. 检验医学与临床, 2019, 16(19): 2811-2813.
  • Related Articles

    [1]HE Jiaqin, WU Hongyan, CAI Qian, LU Yu, LIU Xinliang. Values of serum triglyceride-glucose index combined with retinol-binding protein and β2-microglobulin in prediction and screening of diabetic retinopathy[J]. Journal of Clinical Medicine in Practice, 2023, 27(18): 70-74. DOI: 10.7619/jcmp.20231267
    [2]FENG Feifei, WU Jiayu, JIANG Lili, XU Yan. Application of combined detection of red blood cell distribution width, ratio of C-reactive protein to albumin and albumin-to-creatinine ratio in predicting complications of type 2 diabetes[J]. Journal of Clinical Medicine in Practice, 2023, 27(15): 45-49. DOI: 10.7619/jcmp.20223479
    [3]HUA Yulin, ZHANG Yuyang, WANG Chen, SUN Hong, SHI Bimin. Application of renal fat detection technology in diabetic patients[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 136-139. DOI: 10.7619/jcmp.20222584
    [4]LIU Jianli, LIU Liming, YANG Xiaoying. Relationships between three islet autoantibodiesand renal damage in children with type 1 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 119-123. DOI: 10.7619/jcmp.20212482
    [5]ZHANG Junfeng, LIU Shengxian, LI Jie. Value of combined detection of four indicators in diagnosis of early renal injury in elderly patients with essential hypertension[J]. Journal of Clinical Medicine in Practice, 2020, 24(14): 97-99. DOI: 10.7619/jcmp.202014026
    [6]YIN Haibin, ZHOU Cheng. Association between Helicobacter pylori infection and early renal damage in children with Henoch-Schonlein purpura[J]. Journal of Clinical Medicine in Practice, 2019, 23(24): 47-50, 54. DOI: 10.7619/jcmp.201924015
    [7]ZHAO Yani, WANG Jun, ZHAO Mian. Value of combined detection of serum β2-MG, RBP, Cys C, NGAL and MMP-2 in patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2018, (13): 20-23. DOI: 10.7619/jcmp.201813006
    [8]GUO Jin. Levels of serum retinol binding protein and cystatin C in patients with hemorrhagic fever with renal syndrome and their correlations with renal damage[J]. Journal of Clinical Medicine in Practice, 2017, (13): 48-50. DOI: 10.7619/jcmp.201713013
    [9]ZHANG Xiajun, HU Mengmou, YAN Xiaohui. Value of detection of serum P-selectin combined with microalbuminuria in early diagnosis of renal impairment of children with Henoch-Sch-nlein purpura[J]. Journal of Clinical Medicine in Practice, 2013, (23): 52-55. DOI: 10.7619/jcmp.201323015
  • Cited by

    Periodical cited type(33)

    1. 姚林,刘连庚,杨漫,冒小红. 血清sdLDL-C、MFG-E8、LRG1联合检测对糖尿病早期肾损伤的诊断价值. 检验医学与临床. 2025(05): 678-682 .
    2. 韩俊杰,武迪,陈志胜,肖扬,森干. 2型糖尿病患者并发糖尿病肾病风险的列线图预测模型与验证研究. 中国全科医学. 2024(09): 1054-1061 .
    3. 林添堂,卢作烁. 尿蛋白及尿微量白蛋白在糖尿病早期肾病中的临床检验价值. 糖尿病新世界. 2024(02): 4-7 .
    4. 曾海莲. 尿微量白蛋白与尿肌酐比值、尿视黄醇结合蛋白及尿β2微球蛋白联合检测对糖尿病肾病的诊断价值. 智慧健康. 2024(02): 45-47+51 .
    5. 胡晓斌,杨轶男,李巧娥,马执彬,白亚娜. 某矿区居民混合金属暴露与早期肾功能损害相关性. 中国环境科学. 2024(04): 2357-2368 .
    6. 林妹妹. 血常规、尿常规与炎性标志物联合检测诊断糖尿病患者早期肾损伤的价值. 黑龙江医药. 2024(04): 935-938 .
    7. 罗敬华,王乐,罗玉娟. 半定量尿液清蛋白/肌酐比值在糖尿病肾病早期筛查中的应用价值. 贵州医药. 2024(11): 1819-1821 .
    8. 陈丽娜,陈慧明,谢春红. 血清胱抑素C联合β_2-微球蛋白检测在糖尿病肾病早期诊断中的应用价值. 广州医药. 2024(12): 1490-1494 .
    9. 钟海平,盛灿梅,王建中,陈婷,魏谷雨. 尿微量白蛋白与肌酐比值联合β_2微球蛋白检测在糖尿病肾病早期诊断中的价值. 基层医学论坛. 2023(07): 82-85 .
    10. 张立,林洁. 血清胱抑素C、视黄醇结合蛋白与β2-微球蛋白检验在早期2型糖尿病肾病中的应用价值分析. 糖尿病新世界. 2023(05): 182-185 .
    11. 江伟芳,王云娟,吴慧琴. 尿糖联合UmAlb水平检测诊断糖尿病早期肾损伤的临床价值分析. 临床医学工程. 2023(07): 937-938 .
    12. 沈志伟,陈军童,王黎亚. 空腹血糖结合β_2-微球蛋白对糖尿病患者肾功能损伤的诊断效能评价. 中国临床医生杂志. 2023(08): 922-924 .
    13. 钱亮. 血清胱抑素C、β_2-微球蛋白及视黄醇结合蛋白检验在早期糖尿病肾病中的应用分析. 中国实用医药. 2023(14): 26-30 .
    14. 阙禄辉,金燕,谢丽. 2型糖尿病肾病的检测指标尿蛋白-肌酐比值与半胱氨酸蛋白酶抑制剂C糖化血红蛋白的相关性探讨. 基层医学论坛. 2023(25): 89-91 .
    15. 钱海英,董玉俊,葛青华. 血清胱抑素C和尿微量白蛋白、尿肌酐联合检测在痛风性肾病早期诊断中的应用价值. 中国实用医刊. 2023(18): 73-76 .
    16. 陈乙明,林燕平,余尚峰,林万雄. 血清胱抑素C、β2微球蛋白、淀粉样蛋白A对早期糖尿病肾病的诊断价值分析. 糖尿病新世界. 2023(19): 55-58 .
    17. 顾帅帅,朱琳,金艳盛,丁岚,范茂虓. 糖尿病肾病患者尿液基质金属蛋白酶组织抑制剂2、胰岛素样生长因子结合蛋白7的水平及其临床意义. 实用临床医药杂志. 2022(13): 35-40 . 本站查看
    18. 陈文青,叶峰山,宋育明. 尿微量白蛋白联合β2微球蛋白在诊断糖尿病肾病中的价值. 糖尿病新世界. 2022(13): 32-35+39 .
    19. 李赛福,陈超群,谭淑仪,黄振升. 尿β_2-微球蛋白、尿视黄醇结合蛋白联合尿微量白蛋白/尿肌酐比值评估2型糖尿病早期肾损伤的临床分析. 中国处方药. 2022(09): 174-176 .
    20. 景鹏鹨,李改. 血清RBP、Cys–C、UACR联合检测在早期糖尿病肾病诊断中的临床意义. 深圳中西医结合杂志. 2022(15): 63-65 .
    21. 杨黎. 糖尿病肾损伤患者血清中性粒细胞明胶酶相关脂质运载蛋白、胱抑素C、视黄醇结合蛋白表达的临床意义. 现代医学与健康研究电子杂志. 2022(21): 28-31 .
    22. 邝春玲,鲁陈,朱苏兰,曹小东,游晓燕. 尿液微量白蛋白、尿β2-MG、尿NAG、尿CRE联合检测在肾早期损伤中的临床应用分析. 现代诊断与治疗. 2022(13): 1949-1951 .
    23. 谢培民,张雁. 联合检测血清β_2-MG、Irisin及尿ALB/Cr对早期糖尿病肾病的诊断价值. 糖尿病新世界. 2022(24): 1-4 .
    24. 缪春霞,郭琳娜,钟晓连. 尿蛋白和尿微量白蛋白在糖尿病肾病检验中的效果分析. 糖尿病新世界. 2022(24): 65-67+71 .
    25. 张现莉. 糖尿病肾病患者D-二聚体、纤维蛋白原、胱抑素C检测价值分析. 糖尿病新世界. 2021(06): 57-59 .
    26. 阮毅,李菁,黄肖容. 早期糖尿病肾病患者血清肾小球滤过率、尿蛋白肌酐比、尿微量白蛋白、糖化血红蛋白水平变化及其临床意义. 实用医院临床杂志. 2021(04): 113-116 .
    27. 高星辰,侯玮玮,吕媛. 血清胱抑素C联合视黄醇结合蛋白检测在新生儿败血症继发肾损伤中的预测价值. 实用临床医药杂志. 2021(14): 49-53 . 本站查看
    28. 占启川,陈云琴. 血糖与尿糖2项检验检测指标在基层医疗糖尿病患者中的临床应用效果及睡眠质量影响分析. 世界睡眠医学杂志. 2021(06): 945-947 .
    29. 赵娟朋,王海燕. 自拟益肾别浊汤联合贝那普利对2型糖尿病早期肾病患者尿蛋白排泄和炎症损伤及Cys-c水平影响. 社区医学杂志. 2021(16): 996-999 .
    30. 鲍瀛. 血清C肽与β_2-微球蛋白联合检测在早期糖尿病肾病诊断中的应用价值. 医疗装备. 2021(18): 39-40 .
    31. 孟永康,雷祝兵,梅茜,董文飞. 用于碟式微流控芯片的尿液生化检测系统研制及应用. 中国光学. 2021(06): 1317-1326 .
    32. 陶绪长,罗丽华,方颖慧. SPECT肾动态显像联合视黄醇结合蛋白在糖尿病患者早期肾损害中的评估价值. 江西医药. 2021(12): 2339-2342 .
    33. 宋佳佳,陈建丰,尹德超,曹永红,张新秀. NLR联合RBP用于妊娠期糖尿病早期肾损害评估的价值. 武警后勤学院学报(医学版). 2021(06): 9-12 .

    Other cited types(5)

Catalog

    Article views (357) PDF downloads (30) Cited by(38)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return